Rocket Lab (NASDAQ:RKLB) CFO Adam Spice Sells 140,157 Shares of Stock

Key Points

• Insider sale: CFO Adam Spice sold 140,157 Rocket Lab shares for approximately $9.93 million under a pre-arranged Rule 10b5-1 plan, reducing his ownership by 10.81%.
• Stock and financial performance: RKLB rose 4.9% to $73.92, but the company remains unprofitable and recently missed quarterly EPS expectations despite exceeding revenue estimates.
• Analyst outlook: Analysts maintain a consensus “Moderate Buy” rating with an average price target of $107.20, while Rocket Lab’s launch backlog and institutional ownership provide support amid competitive and valuation risks.

Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) CFO Adam Spice sold 140,157 shares of the firm's stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $70.82, for a total transaction of $9,925,918.74. Following the sale, the chief financial officer owned 1,155,967 shares in the company, valued at $81,865,582.94. This trade represents a 10.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Rocket Lab Stock Up 4.9%

RKLB traded up $3.46 during trading on Friday, reaching $73.92. 26,727,281 shares of the stock were exchanged, compared to its average volume of 23,093,701. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. The stock's 50 day moving average price is $69.57 and its two-hundred day moving average price is $84.41. Rocket Lab Corporation has a twelve month low of $37.57 and a twelve month high of $151.00. The stock has a market cap of $44.23 billion, a P/E ratio of -273.77 and a beta of 2.93.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last issued its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%.The business had revenue of $234.07 million for the quarter, compared to the consensus estimate of $231.62 million. Equities analysts expect that Rocket Lab Corporation will post -0.2 EPS for the current year.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Record Synspective contract: Rocket Lab signed a multi-year agreement for 20 Electron launches between 2028 and 2031. The deal lifts Synspective’s total planned missions to 47 and pushes Rocket Lab’s launch backlog above 100 missions, strengthening visibility for future launch revenue. Rocket Lab’s 20-Launch Synspective Deal Pushes Backlog Above 100 Missions
• Positive Sentiment: Wall Street support: Citi initiated coverage with a Buy rating and a $105 price target, calling RKLB a potential “core holding for space bulls.” Other analysts cited in recent coverage see substantial upside, supporting the stock’s rebound. Rocket Lab Stock Rises on Record Electron Launch Deal and Citi Buy Rating
• Positive Sentiment: Institutional buying: Cathie Wood’s ARK Invest ETFs reportedly purchased more than $41 million of Rocket Lab shares across ARKK, ARKQ and ARKX. The buying reflects confidence in Electron, the company’s space-systems business and its planned Neutron rocket. Cathie Wood Is Buying Rocket Lab Again
• Neutral Sentiment: Competitive backdrop: SpaceX’s successful Starship orbital test highlights both the opportunity and the threat for Rocket Lab. Larger, potentially lower-cost rockets could pressure launch economics, increasing the importance of Rocket Lab’s differentiated, dedicated-launch strategy and Neutron’s development.
• Negative Sentiment: Risks remain: The Synspective contract’s financial terms were not disclosed, Rocket Lab remains unprofitable, and its latest reported quarter missed the consensus EPS estimate despite exceeding revenue expectations. Extensive insider selling—including sales by CEO Peter Beck—may also weigh on sentiment and raises valuation concerns after the recent rally.

Hedge Funds Weigh In On Rocket Lab

Several hedge funds and other institutional investors have recently added to or reduced their stakes in RKLB. Versant Capital Management Inc grew its position in shares of Rocket Lab by 5.1% in the 2nd quarter. Versant Capital Management Inc now owns 2,049 shares of the rocket manufacturer's stock worth $208,000 after buying an additional 100 shares during the period. Bartlett & CO. Wealth Management LLC lifted its position in Rocket Lab by 7.1% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 1,869 shares of the rocket manufacturer's stock valued at $120,000 after acquiring an additional 124 shares in the last quarter. Sovereign Financial Group Inc. boosted its position in shares of Rocket Lab by 3.9% during the first quarter. Sovereign Financial Group Inc. now owns 3,320 shares of the rocket manufacturer's stock valued at $213,000 after buying an additional 125 shares during the last quarter. Parvin Asset Management LLC boosted its holdings in shares of Rocket Lab by 4.0% during the 1st quarter. Parvin Asset Management LLC now owns 3,665 shares of the rocket manufacturer's stock valued at $235,000 after acquiring an additional 140 shares during the last quarter. Finally, DMC Group LLC grew its position in Rocket Lab by 5.0% in the 2nd quarter. DMC Group LLC now owns 3,553 shares of the rocket manufacturer's stock worth $361,000 after purchasing an additional 170 shares during the period. 71.78% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on RKLB shares. Citizens Jmp restated a "market outperform" rating and issued a $130.00 price target on shares of Rocket Lab in a research report on Tuesday, August 11th. Needham & Company LLC reiterated a "buy" rating on shares of Rocket Lab in a report on Tuesday, August 11th. Bank of America lowered their price target on Rocket Lab from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Monday, August 31st. Weiss Ratings reiterated a "sell (d-)" rating on shares of Rocket Lab in a research note on Friday, July 17th. Finally, KeyCorp reissued an "overweight" rating on shares of Rocket Lab in a report on Tuesday, August 11th. Four analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $107.20.

About Rocket Lab

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab's primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.